Tampa-based med tech startup eRemede recently closed a $1.55 million seed funding round, which will help the company fully integrate its platform into the world of telehealth.
eRemede, formerly known as eCover Global, is an app that allows doctors and patients to communicate with each other while keeping patient and doctor information private. It was one of the first companies at the Tampa Bay Wave incubator.
The group closed a $1.55 million seed fund round with two angel investors, eRemede CEO and Founder Ben Sever told the Catalyst.
The closing of the seed fund is essential for the company to immerse itself in the telehealth space.
“We are fully built out to support the patient journey through pre-and post-surgical recovery with our mobile platform that allows HIPAA [Health Insurance Portability and Accountability Act]-compliant interactions with doctors,” Sever said. “We are now going to expand into telehealth, meaning the robust data a patient will need will be accessible from one platform. A lot of companies that use telehealth have messaging outside of one mobile platform. Our app would have everything you can do without leaving the platform.”
The app allows data to be aggregated on one platform while keeping information private and protected, at a lower cost to patients and hospitals, which Sever says is critical given the cybersecurity issues with people jumping from one platform to the next.
eRemede initially worked with groups in the surgical spaces, but now considers itself specialty agnostic.
As eRemede enters the growing telehealth space, it also plans to seek additional funding and more employees.
Sever said he plans to close a Series A funding round by the first or second quarter of next year.
The company currently has 15 employees; Sever expects to hire many more and grow the company’s presence.
“I see the Wave as our C-suite and as we bring on more employees, we want another office that’s a true coworking space in Tampa and also one in St. Pete,” Sever said.